bluebird bio Reports Third Quarter 2015 Financial Results and Recent Operational Progress
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Nasdaq, S&P end lower as tech stocks fall
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Strong earthquake rocks north-central Venezuela, capital Caracas
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
bluebird bio (BLUE) Posts Wider-than-Expected Q3 Loss
November 5, 2015 6:45 AM ESTbluebird bio (NASDAQ: BLUE) reported Q3 EPS of ($1.18), $0.24 worse than the analyst estimate of ($0.94). Revenue for the quarter came in at $1.32 million versus the consensus estimate of $5.2 million.
Cash, cash equivalents and marketable securities as of September 30, 2015 were $901.7 million, compared to $492.0 million as of... More
bluebird bio (BLUE) Bullish View Reiterate at Post Q3 and Ahead of ASH Abstract Data -Oppenheimer
November 5, 2015 6:38 AM ESTOppenheimer analyst Wendy Lam reiterated an Outperform rating and $162 price target on bluebird bio (NASDAQ: BLUE) following Q3 results.
Lam commented, "BLUE reported 3Q15 loss per share of ($1.18) and ended the quarter with $901.7M in cash, cash equivalents, and marketable securities; we have updated our... More
